{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:50:53Z","timestamp":1790823053534,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1038\/s41401-024-01331-7","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T08:02:35Z","timestamp":1720598555000},"page":"2380-2393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity"],"prefix":"10.1038","volume":"45","author":[{"given":"Yin-yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-dong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-long","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-rui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-zu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727\u201333.","journal-title":"N Engl J Med."},{"key":"1331_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141\u201354.","journal-title":"Nat Rev Microbiol."},{"key":"1331_CR3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMp038238","volume":"350","author":"J Treanor","year":"2004","unstructured":"Treanor J. Influenza vaccine\u2013outmaneuvering antigenic shift and drift. N Engl J Med. 2004;350:218\u201320.","journal-title":"N Engl J Med."},{"key":"1331_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"F Krammer","year":"2018","unstructured":"Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, et al. Influenza. Nat Rev Dis Prim. 2018;4:3.","journal-title":"Nat Rev Dis Prim"},{"key":"1331_CR5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00705-018-3708-y","volume":"163","author":"B Kumar","year":"2018","unstructured":"Kumar B, Asha K, Khanna M, Ronsard L, Meseko CA, Sanicas M. The emerging influenza virus threat: status and new prospects for its therapy and control. Arch Virol. 2018;163:831\u201344.","journal-title":"Arch Virol."},{"key":"1331_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","volume":"12","author":"JK Taubenberger","year":"2006","unstructured":"Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12:15\u201322.","journal-title":"Emerg Infect Dis."},{"key":"1331_CR7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/viro.1993.1319","volume":"194","author":"JR Sch\u00e4fer","year":"1993","unstructured":"Sch\u00e4fer JR, Kawaoka Y, Bean WJ, S\u00fcss J, Senne D, Webster RG. Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology. 1993;194:781\u20138.","journal-title":"Virology"},{"key":"1331_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0929-6646(09)60102-9","volume":"105","author":"YC Hsieh","year":"2006","unstructured":"Hsieh YC, Wu TZ, Liu DP, Shao PL, Chang LY, Lu CY, et al. Influenza pandemics: past, present and future. J Formos Med Assoc. 2006;105:1\u20136.","journal-title":"J Formos Med Assoc."},{"key":"1331_CR9","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00040-22","volume":"36","author":"R Kumari","year":"2023","unstructured":"Kumari R, Sharma SD, Kumar A, Ende Z, Mishina M, Wang Y, et al. Antiviral approaches against influenza virus. Clin Microbiol Rev. 2023;36:e0004022.","journal-title":"Clin Microbiol Rev."},{"key":"1331_CR10","doi-asserted-by":"crossref","first-page":"116172","DOI":"10.1016\/j.ejmech.2024.116172","volume":"267","author":"G Kumar","year":"2024","unstructured":"Kumar G, Sakharam KA. Tackling influenza A virus by M2 ion channel blockers: latest progress and limitations. Eur J Med Chem. 2024;267:116172.","journal-title":"Eur J Med Chem."},{"key":"1331_CR11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","volume":"366","author":"RA Bright","year":"2005","unstructured":"Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet. 2005;366:1175\u201381.","journal-title":"Lancet"},{"key":"1331_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2020.01.005","volume":"220","author":"M Toots","year":"2020","unstructured":"Toots M, Plemper RK. Next-generation direct-acting influenza therapeutics. Transl Res. 2020;220:33\u201342.","journal-title":"Transl Res."},{"key":"1331_CR13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-405880-4.00006-8","volume":"67","author":"E van der Vries","year":"2013","unstructured":"van der Vries E, Schutten M, Fraaij P, Boucher C, Osterhaus A. Influenza virus resistance to antiviral therapy. Adv Pharmacol. 2013;67:217\u201346.","journal-title":"Adv Pharmacol."},{"key":"1331_CR14","doi-asserted-by":"crossref","first-page":"735305","DOI":"10.3389\/fmicb.2021.735305","volume":"12","author":"MG Hossain","year":"2021","unstructured":"Hossain MG, Akter S, Dhole P, Saha S, Kazi T, Majbauddin A, et al. Analysis of the genetic diversity associated with the drug resistance and pathogenicity of influenza A virus isolated in Bangladesh from 2002 to 2019. Front Microbiol. 2021;12:735305.","journal-title":"Front Microbiol."},{"key":"1331_CR15","doi-asserted-by":"crossref","first-page":"19784","DOI":"10.2807\/ese.16.05.19784-en","volume":"16","author":"A Lackenby","year":"2011","unstructured":"Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, Bolotin S, et al. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010\/11. Eur Surveill. 2011;16:19784.","journal-title":"Eur Surveill"},{"key":"1331_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcv.2011.05.019","volume":"52","author":"C Renaud","year":"2011","unstructured":"Renaud C, Kuypers J, Englund JA. Emerging oseltamivir resistance in seasonal and pandemic influenza A\/H1N1. J Clin Virol. 2011;52:70\u20138.","journal-title":"J Clin Virol."},{"key":"1331_CR17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s40265-020-01350-8","volume":"80","author":"M Shirley","year":"2020","unstructured":"Shirley M. Baloxavir Marboxil: a review in acute uncomplicated influenza. Drugs. 2020;80:1109\u201318.","journal-title":"Drugs"},{"key":"1331_CR18","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00154-23","volume":"97","author":"BT Hickerson","year":"2023","unstructured":"Hickerson BT, Petrovskaya SN, Dickensheets H, Donnelly RP, Ince WL, Ilyushina NA. Impact of baloxavir resistance-associated substitutions on influenza virus growth and drug susceptibility. J Virol. 2023;97:e0015423.","journal-title":"J Virol."},{"key":"1331_CR19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379:913\u201323.","journal-title":"N Engl J Med"},{"key":"1331_CR20","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","volume":"285","author":"SJ Gamblin","year":"2010","unstructured":"Gamblin SJ, Skehel JJ. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem. 2010;285:28403\u20139.","journal-title":"J Biol Chem."},{"key":"1331_CR21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tim.2018.03.005","volume":"26","author":"CJ Russell","year":"2018","unstructured":"Russell CJ, Hu M, Okda FA. Influenza hemagglutinin protein stability, activation, and pandemic risk. Trends Microbiol. 2018;26:841\u201353.","journal-title":"Trends Microbiol"},{"key":"1331_CR22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69:531\u201369.","journal-title":"Annu Rev Biochem."},{"key":"1331_CR23","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","volume":"9","author":"D Dou","year":"2018","unstructured":"Dou D, Revol R, \u00d6stbye H, Wang H, Daniels R. Influenza A virus cell entry, replication, virion assembly and movement. Front Immunol. 2018;9:1581.","journal-title":"Front Immunol."},{"key":"1331_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrmicro3367","volume":"13","author":"AJ Eisfeld","year":"2015","unstructured":"Eisfeld AJ, Neumann G, Kawaoka Y. At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol. 2015;13:28\u201341.","journal-title":"Nat Rev Microbiol."},{"key":"1331_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13543784.2017.1269170","volume":"26","author":"LY Zeng","year":"2017","unstructured":"Zeng LY, Yang J, Liu S. Investigational hemagglutinin-targeted influenza virus inhibitors. Expert Opin Investig Drugs. 2017;26:63\u201373.","journal-title":"Expert Opin Investig Drugs"},{"key":"1331_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/med.21289","volume":"34","author":"E Vanderlinden","year":"2014","unstructured":"Vanderlinden E, Naesens L. Emerging antiviral strategies to interfere with influenza virus entry. Med Res Rev. 2014;34:301\u201339.","journal-title":"Med Res Rev."},{"key":"1331_CR27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbrc.2010.05.161","volume":"397","author":"L Du","year":"2010","unstructured":"Du L, Zhao G, Zhang X, Liu Z, Yu H, Zheng BJ, et al. Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies. Biochem Biophys Res Commun. 2010;397:580\u20135.","journal-title":"Biochem Biophys Res Commun."},{"key":"1331_CR28","first-page":"e00062","volume":"3","author":"K Zhang","year":"2015","unstructured":"Zhang K, He J, Li C, Bose ME, Henrickson KJ, Zhou J, et al. Complete genome sequences of one human respiratory syncytial antigenic group a virus from China and its four mouse-adapted isolates. Genome Announc. 2015;3:e00062\u201315.","journal-title":"Genome Announc"},{"key":"1331_CR29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Epidemiol. 1938;27:493\u20137.","journal-title":"Am J Epidemiol."},{"key":"1331_CR30","volume":"96","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wu Y, Chen S, Zhan Q, Wu D, Yang C, et al. Sertraline is an effective SARS-CoV-2 entry inhibitor targeting the spike protein. J Virol. 2022;96:e0124522.","journal-title":"J Virol."},{"key":"1331_CR31","volume":"162","author":"X Zhang","year":"2023","unstructured":"Zhang X, Li A, Li T, Shou Z, Li Y, Qiao X, et al. A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replication in vitro and in vivo. Biomed Pharmacother. 2023;162:114595.","journal-title":"Biomed Pharmacother."},{"key":"1331_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114825","volume":"163","author":"AC Zwygart","year":"2023","unstructured":"Zwygart AC, Medaglia C, Huber R, Poli R, Marcourt L, Schnee S, et al. Antiviral properties of trans-\u03b4-viniferin derivatives against enveloped viruses. Biomed Pharmacother. 2023;163:114825.","journal-title":"Biomed Pharmacother."},{"key":"1331_CR33","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1021\/jm5014067","volume":"57","author":"M Yu","year":"2014","unstructured":"Yu M, Si L, Wang Y, Wu Y, Yu F, Jiao P, et al. Discovery of pentacyclic triterpenoids as potential entry inhibitors of influenza viruses. J Med Chem. 2014;57:10058\u201371.","journal-title":"J Med Chem."},{"key":"1331_CR34","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.bmc.2008.06.049","volume":"16","author":"AL Liu","year":"2008","unstructured":"Liu AL, Wang HD, Lee SM, Wang YT, Du GH. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg Med Chem. 2008;16:7141\u20137.","journal-title":"Bioorg Med Chem."},{"key":"1331_CR35","first-page":"1999","volume":"8","author":"W Wu","year":"2015","unstructured":"Wu W, Li R, Li X, He J, Jiang S, Liu S, et al. Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry. Viruses. 2015;8:1999\u20134915.","journal-title":"Viruses"},{"key":"1331_CR36","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.31557\/APJCP.2023.24.6.2157","volume":"24","author":"N Kumar","year":"2023","unstructured":"Kumar N, Delu V, Shukla A, Singh RK, Ulasov I, Fayzullina D, et al. Safety assessment of a nucleoside analogue FNC (2\u2019-deoxy-2\u2019-\u03b2-fluoro-4\u2019-azidocytidine) in Balb\/c mice: acute toxicity study. Asian Pac J Cancer Prev. 2023;24:2157\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1331_CR37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jb\/mvab019","volume":"169","author":"J Yang","year":"2021","unstructured":"Yang J, Zhang B, Huang Y, Liu T, Zeng B, Chai J, et al. Antiviral activity and mechanism of ESC-1GN from skin secretion of Hylarana guentheri against influenza A virus. J Biochem. 2021;169:757\u201365.","journal-title":"J Biochem"},{"key":"1331_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","volume":"64","author":"N Pica","year":"2013","unstructured":"Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med. 2013;64:189\u2013202.","journal-title":"Annu Rev Med."},{"key":"1331_CR39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2009.07.022","volume":"85","author":"JC Tilton","year":"2010","unstructured":"Tilton JC, Doms RW. Entry inhibitors in the treatment of HIV-1 infection. Antivir Res. 2010;85:91\u2013100.","journal-title":"Antivir Res"},{"key":"1331_CR40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/ph14060587","volume":"14","author":"Z Chen","year":"2021","unstructured":"Chen Z, Cui Q, Caffrey M, Rong L, Du R. Small molecule inhibitors of influenza virus entry. Pharmaceuticals. 2021;14:587.","journal-title":"Pharmaceuticals"},{"key":"1331_CR41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","volume":"114","author":"RU Kadam","year":"2017","unstructured":"Kadam RU, Wilson IA. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc Natl Acad Sci USA 2017;114:206\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1331_CR42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","volume":"15","author":"YS Boriskin","year":"2008","unstructured":"Boriskin YS, Leneva IA, P\u00e9cheur EI, Polyak SJ. Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Curr Med Chem. 2008;15:997\u20131005.","journal-title":"Curr Med Chem."},{"key":"1331_CR43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","volume":"107","author":"J Blaising","year":"2014","unstructured":"Blaising J, Polyak SJ, P\u00e9cheur EI. Arbidol as a broad-spectrum antiviral: an update. Antivir Res. 2014;107:84\u201394.","journal-title":"Antivir Res"},{"key":"1331_CR44","doi-asserted-by":"crossref","first-page":"e76363","DOI":"10.1371\/journal.pone.0076363","volume":"8","author":"A Antanasijevic","year":"2013","unstructured":"Antanasijevic A, Cheng H, Wardrop DJ, Rong L, Caffrey M. Inhibition of influenza H7 hemagglutinin-mediated entry. PLoS One. 2013;8:e76363.","journal-title":"PLoS One"},{"key":"1331_CR45","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ejphar.2011.04.013","volume":"660","author":"S Liu","year":"2011","unstructured":"Liu S, Li R, Zhang R, Chan CC, Xi B, Zhu Z, et al. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. Eur J Pharmacol. 2011;660:460\u20137.","journal-title":"Eur J Pharmacol."}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01331-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01331-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01331-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T21:05:11Z","timestamp":1729285511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01331-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01331-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"16 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}